A Dose Finding Study Of A New Medication, PF-00337210 That Will Possibly Decrease Blood Supply To Tumors

NCT01105533 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasm

Interventions

DRUG: PF-00337210
DRUG: PF-00337210
DRUG: PF-00337210
DRUG: PF-00337210
DRUG: PF-00337210
DRUG: PF-00337210
DRUG: PF-00337210
DRUG: PF-00337210
DRUG: PF-00337210
DRUG: PF-00337210

Sponsor

Pfizer

Collaborators

[object Object]